The World Health Organisation (WHO) prequalifies tests for HIV, malaria, and other infectious diseases. The purpose of prequalification is to ensure that the products meet high standards of quality and safety. This is important to protect the public against unsafe or ineffective products. The current standards aren’t adequate, but the World Wide Web is a great help. It helps to know what the standards are for a specific product, so that you can avoid buying substandard or counterfeit products.
WHO has been releasing new guidelines for prequalifying HIV diagnostic tests. The WHO recommends two new qualitative HIV assays in November 2016. The Xpert HIV-1 Qual Assay and Alere q HIV-1/2 Detect have been independently evaluated and approved by WHO’s guideline review group. However, they are only appropriate for laboratories equipped with electricity. Therefore, they cannot be used in primary healthcare settings.
The WHO has been releasing recommendations for prequalifying newborn HIV testing. These guidelines are essential for identifying infants who need immediate HIV treatment. In addition to these guidelines, the World Health Organization has been focusing on the development of diagnostic tools for children and infants. The updated guidelines focus on ensuring that these tests are reliable and easy to use. To this end, WHO has been conducting an evaluation of two diagnostic tools to help countries choose the best ones for their specific needs.
In June 2016, the WHO prequalified two qualitative HIV assays for use in infants and children. While these are considered near-POC technology, they require electricity and are not appropriate for primary care settings. The testing results obtained by these tests will need to be validated before they can be used in a clinic. It is important to note that this new test is only available in labs with electricity.
The early identification of infants and children with HIV infection is essential to preventing the spread of the virus. Because early detection is essential to early ART, the WHO has developed recommendations for newborn and child HIV testing. The guidelines were reviewed in November 2008 by a guideline review group that consisted of experts from around the world. This group included scientists from the United States, Canada, the Netherlands, and Canada.
The World Health Organization (WHO) prequalified two qualitative HIV tests in June 2016 for use in pediatric and infant clinics. The tests are near-POC technology, and they can be used in primary care settings without electricity. There are still more questions than answers, but there is no shortage of ways to respond to the challenge. These diagnostic tests help identify infants and children with HIV. They are crucial to the early diagnosis of HIV.
